Astley-Sparke Philip — SEC insider filings

SEC reporting owner CIK 1376491. 18 insider filings on record with FilingPulse; latest filed 2026-08-24.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2020-12-11 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Replimune Group, Inc. (REPL)Director14—21 legs · 215,398 sh · $5,416,58611
uniQure N.V. (QURE)Director2—1 leg · 504 sh · $18,9502
enGene Therapeutics Inc. (ENGN)Director2——2

Insider filings — Astley-Sparke Philip

FiledFormIssuerReported transactionsSource
2026-08-244Replimune Group, Inc. (REPL)Gift (G): 50,000 @ $0EDGAR
2026-06-174enGene Therapeutics Inc. (ENGN)Grant/award (A): 31,000 (derivative) @ $0EDGAR
2026-05-204Replimune Group, Inc. (REPL)Sale (S): 17,657 @ $5.08EDGAR
2026-04-074Replimune Group, Inc. (REPL)Grant/award (A): 50,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2026-02-204Replimune Group, Inc. (REPL)Gift (G): 25,000 @ $0EDGAR
2025-07-104enGene Holdings Inc. (ENGN)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-05-224Replimune Group, Inc. (REPL)Sale (S): 32,279 @ $8.06EDGAR
2024-08-304Replimune Group, Inc. (REPL)Gift (G): 50,000 @ $0EDGAR
2024-05-204Replimune Group, Inc. (REPL)Sale (S): 37,928 @ $6.47EDGAR
2023-05-184Replimune Group, Inc. (REPL)Sale (S): 17,902 @ $18.05EDGAR
2023-04-044Replimune Group, Inc. (REPL)Grant/award (A): 142,100 @ $0 · Grant/award (A): 213,150 (derivative) @ $0EDGAR
2022-05-184Replimune Group, Inc. (REPL)Sale (S): 9,632 @ $14.59EDGAR
2022-04-054Replimune Group, Inc. (REPL)Grant/award (A): 70,000 @ $0 · Grant/award (A): 105,000 (derivative) @ $0EDGAR
2021-04-054Replimune Group, Inc. (REPL)Grant/award (A): 85,415 @ $0 · Grant/award (A): 128,125 (derivative) @ $0EDGAR
2021-03-044uniQure N.V. (QURE)Sale (S): 504 @ $37.60EDGAR
2021-03-014uniQure N.V. (QURE)Grant/award (A): 2,382 @ $0 · Grant/award (A): 4,107 (derivative) @ $0EDGAR
2021-01-194Replimune Group, Inc. (REPL)Sale (S): 17,452 @ $44.78 · Sale (S): 7,448 @ $43.61 · Sale (S): 100 @ $43.06 · Sale (S): 1,100 @ $44.95 · Sale (S): 6,059 @ $43.71 · Sale (S): 9,409 @ $43.02 · +2 moreEDGAR
2020-12-114Replimune Group, Inc. (REPL)Sale (S): 600 @ $45.79 · Sale (S): 6,025 @ $44.85 · Sale (S): 6,459 @ $43.88 · Sale (S): 11,116 @ $43.09 · Sale (S): 800 @ $42.03 · Sale (S): 5,086 @ $43.72 · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1376491 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs